Download PDF
Semin Thromb Hemost 2006; 32: 069-076
DOI: 10.1055/s-2006-939556
Copyright © 2006 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA.

Activation of Microglial Cells by Thrombin: Past, Present, and Future

Thomas Möller1 , 2 , Jonathan R. Weinstein1 , Uwe-Karsten Hanisch3
  • 1Department of Neurology, School of Medicine, University of Washington, Seattle, Washington
  • 2Center for Neurogenetics and Neurotherapeutics, University of Washington, Seattle, Washington
  • 3Institute for Neuropathology, University of Göttingen, Göttingen, Germany
Further Information

Publication History

Publication Date:
02 May 2006 (online)

    Permissions and Reprints

ABSTRACT

In addition to its role in the coagulation cascade, the serine proteinase thrombin (factor IIa) activates cell surface proteinase-activated receptors (PARs) both within and outside the vascular system. PARs are expressed in the central nervous system and mediate thrombin-induced cellular responses in a variety of neural cell types, including microglial cells. Microglial activation by thrombin was reported to induce proliferation, cytokine release, and intracellular calcium signaling. Recently, additional experiments questioned whether these effects are mediated either by thrombin's proteolytic activity or by thrombin itself. Analysis of commercially available plasma-derived thrombin frequently used in the earlier studies showed that cyto/chemokine release-activating properties were not residing with thrombin but were with high molecular weight contaminant(s). In the absence of such contamination, no microglial activation was seen. We compared commercial-grade plasma-derived thrombin to pharmaceutical-grade recombinant thrombin devoid of any measurable contamination. The pharmaceutical-grade thrombin displayed a much more limited profile of microglia-activating properties, triggering only intracellular calcium signals and small changes in surface antigen expression. The signals induced by the pharmaceutical-grade thrombin were completely abolished by proteolytic inhibition, indicating that they are proteolysis-dependent, are most likely PAR mediated, and reflect thrombin's true microglia-activating potential. Prior reports using nonpharmaceutical-grade thrombin need to be reinterpreted critically given these new findings.

KEYWORDS

Blood coagulation - central nervous system - microglia - proteinase-activated receptors - thrombin

REFERENCES

  • 1 Gurwitz D, Cunningham D D. Thrombin modulates and reverses neuroblastoma neurite outgrowth.  Proc Natl Acad Sci USA. 1988;  85 3440-3444
    PubMedGoogle Scholar
  • 2 Suidan H S, Stone S R, Hemmings B A, Monard D. Thrombin causes neurite retraction in neuronal cells through activation of cell surface receptors.  Neuron. 1992;  8 363-375
    CrossrefPubMedGoogle Scholar
  • 3 Cavanaugh K P, Gurwitz D, Cunningham D D, Bradshaw R A. Reciprocal modulation of astrocyte stellation by thrombin and protease nexin-1.  J Neurochem. 1990;  54 1735-1743
    PubMedGoogle Scholar
  • 4 Beecher K L, Andersen T T, Fenton J W, Festoff B W. Thrombin receptor peptides induce shape change in neonatal murine astrocytes in culture.  J Neurosci Res. 1994;  37 108-115
    CrossrefPubMedGoogle Scholar
  • 5 Grabham P, Cunningham D D. Thrombin receptor activation stimulates astrocyte proliferation and reversal of stellation by distinct pathways: involvement of tyrosine phosphorylation.  J Neurochem. 1995;  64 583-591
    PubMedGoogle Scholar
  • 6 Ubl J J, Reiser G. Characteristics of thrombin-induced calcium signals in rat astrocytes.  Glia. 1997;  21 361-369
    CrossrefPubMedGoogle Scholar
  • 7 Smith-Swintosky V L, Zimmer S, Fenton J W, Mattson M P. Protease nexin-1 and thrombin modulate neuronal Ca2+ homeostasis and sensitivity to glucose deprivation-induced injury.  J Neurosci. 1995;  15 5840-5850
    PubMedGoogle Scholar
  • 8 Vaughan P J, Pike C J, Cotman C W, Cunningham D D. Thrombin receptor activation protects neurons and astrocytes from cell death produced by environmental insults.  J Neurosci. 1995;  15 5389-5401
    PubMedGoogle Scholar
  • 9 Festoff B W, Smirnova I V, Ma J, Citron B A. Thrombin, its receptor and protease nexin I, its potent serpin, in the nervous system.  Semin Thromb Hemost. 1996;  22 267-271
    Article in Thieme ConnectPubMedGoogle Scholar
  • 10 Suidan H S, Niclou S P, Monard D. The thrombin receptor in the nervous system.  Semin Thromb Hemost. 1996;  22 125-133
    PubMedGoogle Scholar
  • 11 Donovan F M, Cunningham D D. Signaling pathways involved in thrombin-induced cell protection.  J Biol Chem. 1998;  273 12746-12752
    CrossrefPubMedGoogle Scholar
  • 12 Weinstein J R, Lau A L, Brass L F, Cunningham D D. Injury-related factors and conditions down-regulate the thrombin receptor (PAR-1) in a human neuronal cell line.  J Neurochem. 1998;  71 1034-1050
    PubMedGoogle Scholar
  • 13 Wang H, Ubl J J, Stricker R, Reiser G. Thrombin (PAR-1)-induced proliferation in astrocytes via MAPK involves multiple signaling pathways.  Am J Physiol Cell Physiol. 2002;  283 C1351-C1364
    PubMedGoogle Scholar
  • 14 Niclou S, Suidan H S, Brown-Luedi M, Monard D. Expression of the thrombin receptor mRNA in rat brain.  Cell Mol Biol. 1994;  40 421-428
    PubMedGoogle Scholar
  • 15 Weinstein J R, Gold S J, Cunningham D D, Gall C M. Cellular localization of thrombin receptor mRNA in rat brain: expression by mesencephalic dopaminergic neurons and codistribution with prothrombin mRNA.  J Neurosci. 1995;  15 2906-2919
    PubMedGoogle Scholar
  • 16 Niclou S P, Suidan H S, Pavlik A, Vejsada R, Monard D. Changes in the expression of protease-activated receptor 1 and protease nexin-1 mRNA during rat nervous system development and after nerve lesion.  Eur J Neurosci. 1998;  10 1590-1607
    CrossrefPubMedGoogle Scholar
  • 17 Wang H, Ubl J J, Reiser G. Four subtypes of protease-activated receptors, co-expressed in rat astrocytes, evoke different physiological signaling.  Glia. 2002;  37 53-63
    CrossrefPubMedGoogle Scholar
  • 18 Wang Y, Richter-Landsberg C, Reiser G. Expression of protease-activated receptors (PARs) in OLN-93 oligodendroglial cells and mechanism of PAR-1-induced calcium signaling.  Neuroscience. 2004;  126 69-82
    CrossrefPubMedGoogle Scholar
  • 19 Liu Y, Fields R D, Festoff B W, Nelson P G. Proteolytic action of thrombin is required for electrical activity-dependent synapse reduction.  Proc Natl Acad Sci USA. 1994;  91 10300-10304
    PubMedGoogle Scholar
  • 20 Nelson P G, Fields R D, Liu Y. Neural activity, neuron-glia relationships, and synapse development.  Perspect Dev Neurobiol. 1995;  2 399-407
    PubMedGoogle Scholar
  • 21 Turgeon V L, Houenou L J. The role of thrombin-like (serine) proteases in the development, plasticity and pathology of the nervous system.  Brain Res Brain Res Rev. 1997;  25 85-95
    CrossrefPubMedGoogle Scholar
  • 22 Festoff B W, Suo Z, Citron B A. Plasticity and stabilization of neuromuscular and CNS synapses: interactions between thrombin protease signaling pathways and tissue transglutaminase.  Int Rev Cytol. 2001;  211 153-177
    PubMedGoogle Scholar
  • 23 Cunningham D D, Pulliam L, Vaughan P J. Protease nexin-1 and thrombin: injury-related processes in the brain.  Thromb Haemost. 1993;  70 168-171
    PubMedGoogle Scholar
  • 24 Grand R J, Turnell A S, Grabham P W. Cellular consequences of thrombin-receptor activation.  Biochem J. 1996;  313(pt 2) 353-368
    PubMedGoogle Scholar
  • 25 Gingrich M B, Traynelis S F. Serine proteases and brain damage-is there a link?.  Trends Neurosci. 2000;  23 399-407
    CrossrefPubMedGoogle Scholar
  • 26 Wang H, Reiser G. Thrombin signaling in the brain: the role of protease-activated receptors.  Biol Chem. 2003;  384 193-202
    CrossrefPubMedGoogle Scholar
  • 27 Deschepper C F, Bigornia V, Berens M E, Lapointe M C. Production of thrombin and antithrombin III by brain and astroglial cell cultures.  Brain Res Mol Brain Res. 1991;  11 355-358
    CrossrefPubMedGoogle Scholar
  • 28 Dihanich M, Kaser M, Reinhard E, Cunningham D, Monard D. Prothrombin mRNA is expressed by cells of the nervous system.  Neuron. 1991;  6 575-581
    CrossrefPubMedGoogle Scholar
  • 29 Citron B A, Smirnova I V, Arnold P M, Festoff B W. Upregulation of neurotoxic serine proteases, prothrombin, and protease-activated receptor 1 early after spinal cord injury.  J Neurotrauma. 2000;  17 1191-1203
    PubMedGoogle Scholar
  • 30 Riek-Burchardt M, Striggow F, Henrich-Noack P, Reiser G, Reymann K G. Increase of prothrombin-mRNA after global cerebral ischemia in rats, with constant expression of protease nexin-1 and protease-activated receptors.  Neurosci Lett. 2002;  329 181-184
    CrossrefPubMedGoogle Scholar
  • 31 Jamison C S, Degen S J. Prenatal and postnatal expression of mRNA coding for rat prothrombin.  Biochim Biophys Acta. 1991;  1088 208-216
    PubMedGoogle Scholar
  • 32 Soifer S J, Peters K G, O'Keefe J, Coughlin S R. Disparate temporal expression of the prothrombin and thrombin receptor genes during mouse development.  Am J Pathol. 1994;  144 60-69
    PubMedGoogle Scholar
  • 33 Walz D A, Anderson G F, Ciaglowski R E, Aiken M, Fenton J W. Thrombin-elicited contractile responses of aortic smooth muscle.  Proc Soc Exp Biol Med. 1985;  180 518-526
    PubMedGoogle Scholar
  • 34 Fenton J W. Thrombin.  Ann N Y Acad Sci. 1986;  485 5-15
    PubMedGoogle Scholar
  • 35 Rubin L L, Staddon J M. The cell biology of the blood-brain barrier.  Annu Rev Neurosci. 1999;  22 11-28
    CrossrefPubMedGoogle Scholar
  • 36 Selmaj K. Pathophysiology of the blood-brain barrier.  Springer Semin Immunopathol. 1996;  18 57-73
    CrossrefPubMedGoogle Scholar
  • 37 Smirnova I V, Salazar A, Arnold P M et al.. Thrombin and its precursor in human cerebrospinal fluid.  Thromb Haemost. 1997;  78 1473-1479
    PubMedGoogle Scholar
  • 38 Kasuya H, Shimizu T, Takakura K. Thrombin activity in CSF after SAH is correlated with the degree of SAH the persistence of subarachnoid clot and the development of vasospasm.  Acta Neurochir (Wien). 1998;  140 579-584
    CrossrefPubMedGoogle Scholar
  • 39 Suzuki M, Kudo A, Otawara Y et al.. Extrinsic pathway of blood coagulation and thrombin in the cerebrospinal fluid after subarachnoid hemorrhage.  Neurosurgery. 1999;  44 487-493
    PubMedGoogle Scholar
  • 40 Choi B H, Suzuki M, Kim T, Wagner S L, Cunningham D D. Protease nexin-1. Localization in the human brain suggests a protective role against extravasated serine proteases.  Am J Pathol. 1990;  137 741-747
    PubMedGoogle Scholar
  • 41 Hoffmann M C, Nitsch C, Scotti A L, Reinhard E, Monard D. The prolonged presence of glia-derived nexin, an endogenous protease inhibitor, in the hippocampus after ischemia-induced delayed neuronal death.  Neuroscience. 1992;  49 397-408
    CrossrefPubMedGoogle Scholar
  • 42 Wagner S L, Geddes J W, Cotman C W et al.. Protease nexin-1, an antithrombin with neurite outgrowth activity, is reduced in Alzheimer disease.  Proc Natl Acad Sci USA. 1989;  86 8284-8288
    PubMedGoogle Scholar
  • 43 Akiyama H, Ikeda K, Kondo H, McGeer P L. Thrombin accumulation in brains of patients with Alzheimer's disease.  Neurosci Lett. 1992;  146 152-154
    CrossrefPubMedGoogle Scholar
  • 44 Streit W J. Microglia as neuroprotective, immunocompetent cells of the CNS.  Glia. 2002;  40 133-139
    CrossrefPubMedGoogle Scholar
  • 45 Kreutzberg G W. Microglia: a sensor for pathological events in the CNS.  Trends Neurosci. 1996;  19 312-318
    CrossrefPubMedGoogle Scholar
  • 46 Carson M J. Microglia as liaisons between the immune and central nervous systems: functional implications for multiple sclerosis.  Glia. 2002;  40 218-231
    CrossrefPubMedGoogle Scholar
  • 47 Danton G H, Dietrich W D. Inflammatory mechanisms after ischemia and stroke.  J Neuropathol Exp Neurol. 2003;  62 127-136
    PubMedGoogle Scholar
  • 48 Davalos D, Grutzendler J, Yang G et al.. ATP mediates rapid microglial response to local brain injury in vivo.  Nat Neurosci. 2005;  8 752-758
    CrossrefPubMedGoogle Scholar
  • 49 Fetler L, Amigorena S. Neuroscience. Brain under surveillance: the microglia patrol.  Science. 2005;  309 392-393
    CrossrefPubMedGoogle Scholar
  • 50 Nimmerjahn A, Kirchhoff F, Helmchen F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo.  Science. 2005;  308 1314-1318
    CrossrefPubMedGoogle Scholar
  • 51 Hanisch U K, van Rossum D, Xie Y et al.. The microglia-activating potential of thrombin: the protease is not involved in the induction of proinflammatory cytokines and chemokines.  J Biol Chem. 2004;  279 51880-51887
    CrossrefPubMedGoogle Scholar
  • 52 van Rossum D, Hanisch U K. Microglia.  Metab Brain Dis. 2004;  19 393-411
    CrossrefPubMedGoogle Scholar
  • 53 Möller T, Hanisch U K, Ransom B R. Thrombin-induced activation of cultured rodent microglia.  J Neurochem. 2000;  75 1539-1547
    CrossrefPubMedGoogle Scholar
  • 54 Ryu J, Pyo H, Jou I, Joe E. Thrombin induces NO release from cultured rat microglia via protein kinase C, mitogen-activated protein kinase, and NF-kappa B.  J Biol Chem. 2000;  275 29955-29959
    CrossrefPubMedGoogle Scholar
  • 55 Suo Z, Wu M, Ameenuddin S et al.. Participation of protease-activated receptor-1 in thrombin-induced microglial activation.  J Neurochem. 2002;  80 655-666
    CrossrefPubMedGoogle Scholar
  • 56 Suo Z, Wu M, Citron B A, Gao C, Festoff B W. Persistent protease-activated receptor 4 signaling mediates thrombin-induced microglial activation.  J Biol Chem. 2003;  278 31177-31183
    CrossrefPubMedGoogle Scholar
  • 57 Balcaitis S, Xie Y, Weinstein J R et al.. Expression of proteinase-activated receptors in mouse microglial cells.  Neuroreport. 2003;  14 2373-2377
    PubMedGoogle Scholar
  • 58 Hanisch U K. Microglia as a source and target of cytokines.  Glia. 2002;  40 140-155
    CrossrefPubMedGoogle Scholar
  • 59 Kim K Y, Kim M Y, Choi H S et al.. Thrombin induces IL-10 production in microglia as a negative feedback regulator of TNF-alpha release.  Neuroreport. 2002;  13 849-852
    PubMedGoogle Scholar
  • 60 Yang M S, Lee J, Ji K A et al.. Thrombin induces suppressor of cytokine signaling 3 expression in brain microglia via protein kinase Cdelta activation.  Biochem Biophys Res Commun. 2004;  317 811-816
    CrossrefPubMedGoogle Scholar
  • 61 Yang M S, Park E J, Sohn S et al.. Interleukin-13 and -4 induce death of activated microglia.  Glia. 2002;  38 273-280
    CrossrefPubMedGoogle Scholar
  • 62 Lee D Y, Oh Y J, Jin B K. Thrombin-activated microglia contribute to death of dopaminergic neurons in rat mesencephalic cultures: dual roles of mitogen-activated protein kinase signaling pathways.  Glia. 2005;  51 98-110
    CrossrefPubMedGoogle Scholar
  • 63 Xue M, Del Bigio M R. Acute tissue damage after injections of thrombin and plasmin into rat striatum.  Stroke. 2001;  32 2164-2169
    CrossrefPubMedGoogle Scholar
  • 64 Carreno-Muller E, Herrera A J, de Pablos R M et al.. Thrombin induces in vivo degeneration of nigral dopaminergic neurones along with the activation of microglia.  J Neurochem. 2003;  84 1201-1214
    CrossrefPubMedGoogle Scholar
  • 65 Choi S H, Joe E H, Kim S U, Jin B K. Thrombin-induced microglial activation produces degeneration of nigral dopaminergic neurons in vivo.  J Neurosci. 2003;  23 5877-5886
    PubMedGoogle Scholar
  • 66 Choi S H, Lee D Y, Kim S U, Jin B K. Thrombin-induced oxidative stress contributes to the death of hippocampal neurons in vivo: role of microglial NADPH oxidase.  J Neurosci. 2005;  25 4082-4090
    CrossrefPubMedGoogle Scholar
  • 67 Suo Z, Citron B A, Festoff B W. Thrombin: a potential proinflammatory mediator in neurotrauma and neurodegenerative disorders.  Curr Drug Targets Inflamm Allergy. 2004;  3 105-114
    CrossrefPubMedGoogle Scholar
  • 68 Weinstein J R, Hong S, Kulman J D et al.. Unraveling thrombin's true microglia-activating potential: markedly disparate profiles of pharmaceutical-grade and commercial-grade thrombin preparations.  J Neurochem. 2005;  95 1177-1187
    CrossrefPubMedGoogle Scholar
  • 69 Choi S H, Lee D Y, Ryu J K et al.. Thrombin induces nigral dopaminergic neurodegeneration in vivo by altering expression of death-related proteins.  Neurobiol Dis. 2003;  14 181-193
    CrossrefPubMedGoogle Scholar
  • 70 Möller T, Kann O, Prinz M et al.. Endothelin-induced calcium signaling in cultured mouse microglial cells is mediated through ETB receptors.  Neuroreport. 1997;  8 2127-2131
    PubMedGoogle Scholar
  • 71 Möller T, Contos J J, Musante D B, Chun J, Ransom B R. Expression and function of lysophosphatidic acid receptors in cultured rodent microglial cells.  J Biol Chem. 2001;  276 25946-25952
    CrossrefPubMedGoogle Scholar
  • 72 Sorensen B B, Rao L V, Tornehave D, Gammeltoft S, Petersen L C. Antiapoptotic effect of coagulation factor VIIa.  Blood. 2003;  102 1708-1715
    CrossrefPubMedGoogle Scholar
  • 73 Donovan F M, Pike C J, Cotman C W, Cunningham D D. Thrombin induces apoptosis in cultured neurons and astrocytes via a pathway requiring tyrosine kinase and RhoA activities.  J Neurosci. 1997;  17 5316-5326
    PubMedGoogle Scholar

Thomas MöllerPh.D. 

Department of Neurology, University of Washington, Box 356465

1959 NE Pacific Street, Seattle, WA 98195

Email: moeller@u.washington.edu

      >